- Home
- DLO vs BHVN Comparison
DLO vs BHVN Comparison
Compare DLO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLO
- BHVN
- Stock Information
- Founded
- DLO 2013
- BHVN 2013
- Country
- DLO Uruguay
- BHVN United States
- Employees
- DLO N/A
- BHVN N/A
- Industry
- DLO Business Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- DLO Consumer Discretionary
- BHVN Health Care
- Exchange
- DLO Nasdaq
- BHVN Nasdaq
- Market Cap
- DLO 3.3B
- BHVN 3.6B
- IPO Year
- DLO 2021
- BHVN 2017
- Fundamental
- Price
- DLO $11.81
- BHVN $37.58
- Analyst Decision
- DLO Hold
- BHVN Strong Buy
- Analyst Count
- DLO 10
- BHVN 13
- Target Price
- DLO $12.45
- BHVN $63.00
- AVG Volume (30 Days)
- DLO 1.0M
- BHVN 1.2M
- Earning Date
- DLO 11-13-2024
- BHVN 02-27-2025
- Dividend Yield
- DLO N/A
- BHVN N/A
- EPS Growth
- DLO N/A
- BHVN N/A
- EPS
- DLO 0.40
- BHVN N/A
- Revenue
- DLO $729,488,000.00
- BHVN N/A
- Revenue This Year
- DLO $15.98
- BHVN N/A
- Revenue Next Year
- DLO $25.99
- BHVN $197.13
- P/E Ratio
- DLO $29.65
- BHVN N/A
- Revenue Growth
- DLO 25.61
- BHVN N/A
- 52 Week Low
- DLO $6.58
- BHVN $26.80
- 52 Week High
- DLO $18.27
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- DLO 58.17
- BHVN 45.91
- Support Level
- DLO $10.50
- BHVN $35.01
- Resistance Level
- DLO $11.73
- BHVN $40.46
- Average True Range (ATR)
- DLO 0.37
- BHVN 2.12
- MACD
- DLO -0.03
- BHVN 0.27
- Stochastic Oscillator
- DLO 78.92
- BHVN 54.02
About DLO DLocal Limited
DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables global enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.